Maikowski & Ninnemann Patentanwälte Partnerschaft mbB

System and method for identifying a malfunction in a peristaltic pump (110) which comprises a rotor (150) with at least one roller (140), the method comprising the steps: obtaining a first upstream pressure value at a first rotor position in which the roller is positioned away from the tubing (120); activating the peristaltic pump until the rotor reaches a second position in which the roller has completed at least one rotation; obtaining a second upstream pressure value when the rotor is in the second position; determining the pressure difference between the first and the second upstream values; and generating an alert if the determination indicates pump operation abnormality. Alternatively, the method may also identify pump malfunction by determining the pressure difference from downstream pressure values.

The present invention refers to a recycling plant comprising at least one process building (200) with at least one pre-processing section (210) and at least one post-processing section (220) and a container yard (300) comprising multiple positions for unloading, storing and/or loading at least partially filled containers and/empty containers. The recycling plant further comprises at least one container transport and tracking system, preferably an automated container transport and tracking system.

An intravenous infusion system includes a plurality of infusion pumps each configured to convey a fluid to a subject during an intravenous infusion procedure, a controller programmed to receive information regarding the pumps, and a display screen configured to receive input from the controller and to display a visual representation of the pumps based at least in part on the input from the controller. The controller may be programmed to determine whether there is a possible negative interaction between operation of at least two of the pumps during the intravenous infusion procedure and to control the display screen to display a notice regarding the negative interaction upon determining that the negative interaction is possible. The controller and display screen may also or alternatively cooperate to determine and display information regarding the locations of fluids during the procedure and/or to determine and display a total fluid intake level.

Systems and methods are provided for driving a syringe pump. The syringe pump includes a syringe, a pusher movably received within a barrel of the syringe, and a drive assembly associated to the pusher and configured to be actuated to move the pusher through the barrel. The drive assembly includes a lead screw associated to the pusher, a planetary gearbox, a first motor associated to the lead screw via the planetary gearbox, and a second motor associated to the lead screw via the planetary gearbox. Actuation of the first motor and/or the second motor causes rotation of the lead screw so as to cause movement of the pusher through the barrel, with the direction and speed of the movement of the pusher through the barrel being dependent upon the direction of rotation and the rotational rate of the lead screw.

Die vorliegende Erfindung betrifft ein Verfahren zum Verpacken von Laminatpaneelen mit Packpapier und damit verpackte Laminatpaneele. Die vorliegende Erfindung betrifft des Weiteren ein Verfahren zum Anordnen und Sichern der verpackten Laminatpaneele auf einer Palette mittels Papierbahnen und Umreifungsbänder und eine entsprechend verpackte Palette.

Die Erfindung betrifft einen Lederfaserstoff, enthaltenda) mindestens 55 Gew.-% vegetabil gegerbte Lederfasern,b) Bindemittel, und, vorzugsweise schwermetallarme oder schwermetallfreie, Additive, undc) Lederabschnitte aus schwermetallfreier Gerbung und/oder Fasern aus dem Faserrecycling und/oder natürliche Fasern und/oder synthetische Fasern.Der Lederfaserstoff ist vorzugsweise arm an bzw. frei von Schwermetallen.Die Erfindung betrifft weiterhin einen Schichtstoff, eine Schichtplatte, einen Formholzersatz oder ein Oberflächendekor, enthaltend den oder bestehend aus dem erfindungsgemäßen Lederfaserstoff Die Erfindung betrifft weiterhin die Verwendung des erfindungsgemäßen Lederfaserstoffs oder des Schichtstoffs in der Möbelindustrie, in der Innenausbauindustrie und dem Freiformenbau oder in der Schuhindustrie.

The invention relates to a computer-implemented method to facilitate verified service requests by a user computing device, comprising receiving application program code distributed by an application service system, wherein the application program code comprises identifying information; extracting the identifying information from the application program code resident on the user computing device; transmitting an access request to the application service system, wherein the access request comprises the identifying information extracted from the application program code resident on the user computing device; receiving, from the application service system, an access token comprising the identifying information extracted from the application program code resident on the user computing device; and transmitting a service request including the access token to the application service system.

Provided is a system for standardizing health data for use by machine-learned models in responding to user queries. A computing system obtains health data for a user from one or more health data sources. The computing system generates standardized health data, wherein the standardized health data is generated by converting the health data into a standardized format usable by a machine-learned model. The computing system receives a user health query from the user. The computing system generates a model input for the machine-learned model comprising the user health query and the standardized health data. The computing system provides the model input to the machine-learned model. The computing system receives a model output from the machine-learned model. The computing system transmits the model output for display to the user.

The present invention relates to the treatment of fibrosis with a cell therapy based on myeloid cells. The invention provides myeloid cells, such as monocytes or macrophages that are resistant to M-CSF induced expression of a profibrotic gene signature. Said myeloid cells may be genetically modified in that the expression or activity of the transcription factors MAFB and/or MAF is reduced, inhibited or abolished. The administration of such myeloid cells to a subject leads to the reduction of fibrosis. Even more surprisingly, it is demonstrated by the invention that cell therapy with genetically engineered myeloid cells shows a dominant effect against the background of resident macrophages and monocytes after administration to mice in vivo. In particular, a dominant effect of Maf-DKO monocytes on the fibrosis-generating microenvironment of the lung is demonstrated, which indicates that these cells can also be used for the treatment of other fibrotic diseases.

Provided is a beam recovery method in a wireless communication system.A beam recovery method performed by a user terminal (UE) may include receiving a beam reference signal (BRS) used for beam management from an enhanced Node B (eNB), when a beam failure event is detected, transmitting a control signal for a beam failure recovery request to the eNB; and, when beam reporting is triggered, reporting a beam measurement result to the eNB in a specific resource.